• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥胖与流产。

Obesity and Miscarriage.

机构信息

Feinberg School of Medicine, Northwestern University, Chicago, Illinois.

Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Northwestern University, Chicago, Illinois.

出版信息

Semin Reprod Med. 2023 Jul;41(3-04):80-86. doi: 10.1055/s-0043-1777759. Epub 2023 Dec 15.

DOI:10.1055/s-0043-1777759
PMID:38101448
Abstract

Obesity affects nearly 40% of reproductive-aged women and has serious implications for women's overall and reproductive health. Women with an elevated body mass index (BMI) have higher rates of anovulation and irregular menses, lower success with fertility treatment, and significantly higher rates of pregnancy complications, such as hypertension/preeclampsia, gestational diabetes, and preterm delivery. Many studies have also shown an association between obesity and early pregnancy loss. However, the causal association between BMI and miscarriage has not been elucidated, likely due to the multifactorial effects that BMI may have on early pregnancy development. In addition, BMI as an isolated variable fails to capture other relevant confounding health risk factors, such as nutrition, physical activity, and insulin resistance. In this review, we will summarize the current literature demonstrating the association between BMI and miscarriage, highlight the research that attempts to explain the association, and finally provide data on therapeutic interventions to improve reproductive outcomes in women suffering from obesity and early pregnancy loss.

摘要

肥胖影响近 40%的育龄妇女,对妇女的整体和生殖健康有严重影响。体重指数(BMI)升高的女性排卵障碍和月经不规律的发生率更高,生育治疗的成功率更低,且妊娠并发症(如高血压/先兆子痫、妊娠期糖尿病和早产)的发生率显著更高。许多研究还表明肥胖与早期妊娠丢失之间存在关联。然而,BMI 与流产之间的因果关联尚未阐明,这可能是由于 BMI 对早期妊娠发育可能具有多种影响。此外,BMI 作为一个孤立的变量未能捕捉到其他相关的混杂健康风险因素,如营养、身体活动和胰岛素抵抗。在这篇综述中,我们将总结目前表明 BMI 与流产之间关联的文献,重点介绍试图解释这种关联的研究,并最终提供有关治疗干预措施的数据,以改善肥胖和早期妊娠丢失的女性的生殖结局。

相似文献

1
Obesity and Miscarriage.肥胖与流产。
Semin Reprod Med. 2023 Jul;41(3-04):80-86. doi: 10.1055/s-0043-1777759. Epub 2023 Dec 15.
2
Association between weight loss and reproductive outcomes among women with overweight or obesity: a cohort study using UK real-world data.超重或肥胖女性体重减轻与生殖结局之间的关联:一项使用英国真实世界数据的队列研究。
Hum Reprod. 2025 Jul 6. doi: 10.1093/humrep/deaf122.
3
Antioxidants for male subfertility.抗氧化剂治疗男性不育。
Cochrane Database Syst Rev. 2022 May 4;5(5):CD007411. doi: 10.1002/14651858.CD007411.pub5.
4
Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility.用于患有多囊卵巢综合征、月经过少和生育力低下的女性的胰岛素增敏药物(二甲双胍、罗格列酮、吡格列酮、D-手性肌醇)。
Cochrane Database Syst Rev. 2017 Nov 29;11(11):CD003053. doi: 10.1002/14651858.CD003053.pub6.
5
Metformin for women who are overweight or obese during pregnancy for improving maternal and infant outcomes.孕期超重或肥胖女性使用二甲双胍以改善母婴结局。
Cochrane Database Syst Rev. 2018 Jul 24;7(7):CD010564. doi: 10.1002/14651858.CD010564.pub2.
6
Antioxidants for female subfertility.用于女性生育力低下的抗氧化剂。
Cochrane Database Syst Rev. 2017 Jul 28;7(7):CD007807. doi: 10.1002/14651858.CD007807.pub3.
7
Antioxidants for male subfertility.用于男性生育力低下的抗氧化剂。
Cochrane Database Syst Rev. 2014(12):CD007411. doi: 10.1002/14651858.CD007411.pub3. Epub 2014 Dec 15.
8
Clomiphene and other antioestrogens for ovulation induction in polycystic ovarian syndrome.克罗米芬及其他抗雌激素药物用于多囊卵巢综合征的促排卵治疗
Cochrane Database Syst Rev. 2016 Dec 15;12(12):CD002249. doi: 10.1002/14651858.CD002249.pub5.
9
Oocyte activation for women following intracytoplasmic sperm injection (ICSI).卵胞浆内单精子注射(ICSI)后女性的卵母细胞激活。
Cochrane Database Syst Rev. 2024 Dec 20;12(12):CD014040. doi: 10.1002/14651858.CD014040.pub2.
10
Aromatase inhibitors (letrozole) for ovulation induction in infertile women with polycystic ovary syndrome.芳香化酶抑制剂(来曲唑)在多囊卵巢综合征不孕妇女中的促排卵作用。
Cochrane Database Syst Rev. 2022 Sep 27;9(9):CD010287. doi: 10.1002/14651858.CD010287.pub4.

引用本文的文献

1
Role of Granulosa Cell Dysfunction in Women Infertility Associated with Polycystic Ovary Syndrome and Obesity.颗粒细胞功能障碍在多囊卵巢综合征和肥胖相关女性不孕症中的作用。
Biomolecules. 2025 Jun 24;15(7):923. doi: 10.3390/biom15070923.
2
The effect of chronic inflammation on female fertility.慢性炎症对女性生育能力的影响。
Reproduction. 2025 Mar 3;169(4). doi: 10.1530/REP-24-0197. Print 2025 Apr 1.
3
Preconception and Early-Pregnancy Body Mass Index in Women and Men, Time to Pregnancy, and Risk of Miscarriage.女性和男性的孕前和孕早期体重指数、妊娠时间和流产风险。
JAMA Netw Open. 2024 Sep 3;7(9):e2436157. doi: 10.1001/jamanetworkopen.2024.36157.